⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNOA News
Sonoma Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
SNOA
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
accessnewswire.com
SNOA
Form 8-K
sec.gov
SNOA
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
accessnewswire.com
SNOA
RNA
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
accessnewswire.com
SNOA
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
accessnewswire.com
SNOA